While the economy expands and contracts, the biopharma industry follows, and many life science companies are announcing both layoffs and expansions.
Tag Archive for: MiroBio
MiroBio and Gilead believe they can offer new, best-in-class assets to patients beset by different autoimmune diseases. The deal includes MiroBio’s lead investigational candidate, MB272, a selective agonist of T, B and dendritic cells that aims to inhibit or blunt activation and suppress an inflammatory immune response.
